BIOATLA INC's ticker is BCAB and the CUSIP is 09077B104. A total of 92 filers reported holding BIOATLA INC in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,750 | +101273.6% | 162,794 | +79.0% | 0.06% | +1.7% |
| Q2 2023 | $273 | +11.9% | 90,935 | 0.0% | 0.06% | +15.4% |
| Q1 2023 | $244 | -14.7% | 90,935 | +162.8% | 0.05% | -20.0% |
| Q4 2022 | $286 | -99.9% | 34,607 | -16.4% | 0.06% | -12.2% |
| Q3 2022 | $318,000 | +55.1% | 41,420 | -42.5% | 0.07% | +60.9% |
| Q2 2022 | $205,000 | – | 72,087 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,624,076 | $9,712,524 | 1.45% |
| Soleus Capital Management, L.P. | 4,321,197 | $11,580,808 | 1.20% |
| Affinity Asset Advisors, LLC | 325,000 | $871,000 | 0.29% |
| SECTORAL ASSET MANAGEMENT INC | 543,009 | $1,455,264 | 0.28% |
| Cormorant Asset Management, LP | 1,181,115 | $3,165 | 0.21% |
| Orbimed Advisors | 3,861,000 | $10,347,480 | 0.20% |
| Vivo Capital, LLC | 637,181 | $1,707,645 | 0.12% |
| Boxer Capital, LLC | 686,347 | $1,839 | 0.09% |
| Atom Investors LP | 55,476 | $148,676 | 0.08% |
| MYDA Advisors LLC | 55,000 | $147,400 | 0.06% |